Nonpeptidic angiotensin II AT1 receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles

Jun Zhang, Jin Liang Wang*, Wei Fa Yu, Zhi Ming Zhou, Wen Chang Tao, Yi Cheng Wang, Wei Zhe Xue, Di Xu, Li Ping Hao, Xiao Feng Han, Fan Fei, Ting Liu, Ai Hua Liang

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Abstract

Both 6-substituted aminocarbonyl and acylamino benzimidazole derivatives were designed and synthesized as nonpeptidic angiotensin II AT1 receptor antagonists. Compounds 6f, 6g, 11e, 11f, 11g, and 12 showed nanomolar AT1 receptor binding affinity and high AT1 receptor selectivity over AT2 receptor in a preliminary pharmacological evaluation. Among them, the two most active compounds 6f (AT1 IC 50 = 3 nM, AT2 IC50 > 10,000 nM, PA 2 = 8.51) and 11g (AT1 IC50 = 0.1 nM, AT 2 IC50 = 149 nM, PA2 = 8.43) exhibited good antagonistic activity in isolated rabbit aortic strip functional assay. In addition, they were orally active AT1 receptor antagonists in spontaneous hypertensive rats.

Original languageEnglish
Pages (from-to)44-54
Number of pages11
JournalEuropean Journal of Medicinal Chemistry
Volume69
DOIs
Publication statusPublished - 2013

Keywords

  • Acylamino benzimidazole
  • Aminoacyl benzimidazole
  • Angiotensin II AT1 receptor antagonists
  • Hypertension

Fingerprint

Dive into the research topics of 'Nonpeptidic angiotensin II AT1 receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles'. Together they form a unique fingerprint.

Cite this